CD8A and neoplasm: A previous study found that TAM depletion with a colony-stimulating factor-1 receptor (CSF-1R) inhibitor enhanced CD8+ T cell motility and infiltration into tumors, and further combination therapy with anti-PD-1 increased the contact between tumor cells and CD8+ T cells [69].